aspirin has been researched along with Atrial Septal Defect in 38 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adding clopidogrel to aspirin for 3 months after transcatheter atrial septal defect (ASD) closure results in a lower incidence of new-onset migraine attacks." | 9.41 | Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial. ( Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J; Wintzer-Wehekind, J, 2021) |
| "The aim of this study is to compare preoperative and postoperative conditions of GMP-140 concentration, the aggregation and activation of platelets in congenital heart disease patients undergoing transcatheter closure of atrial septal defects (ASDs) or ventricular septal defects (VSDs), and the appropriate dose of aspirin of patients after transcatheter closure." | 9.19 | Platelet activation through the efficacy of aspirin in congenital heart disease patients undergoing transcatheter closure of atrial septal defects or ventricular septal defects. ( Long, SC; Pan, G; Xie, ZF; Xu, XP; Zhang, Y; Zhang, ZW, 2014) |
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 7.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| "The present study was undertaken to evaluate the safety and release of nickel after implantation of a nickel device (Amplatzer occluder) in patients with an atrial septal defect (ASD) receiving antiplatelet therapy." | 7.73 | Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder. ( Brandt, R; Burian, M; Geisslinger, G; Hamm, C; Mitrovic, V; Neumann, T; Weber, M, 2006) |
| "The occurrence of new-onset migraine attacks is a complication of transcatheter atrial septal defect (ASD) closure." | 6.80 | Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial. ( Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J, 2015) |
| "Adding clopidogrel to aspirin for 3 months after transcatheter atrial septal defect (ASD) closure results in a lower incidence of new-onset migraine attacks." | 5.41 | Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial. ( Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J; Wintzer-Wehekind, J, 2021) |
| "The aim of this study is to compare preoperative and postoperative conditions of GMP-140 concentration, the aggregation and activation of platelets in congenital heart disease patients undergoing transcatheter closure of atrial septal defects (ASDs) or ventricular septal defects (VSDs), and the appropriate dose of aspirin of patients after transcatheter closure." | 5.19 | Platelet activation through the efficacy of aspirin in congenital heart disease patients undergoing transcatheter closure of atrial septal defects or ventricular septal defects. ( Long, SC; Pan, G; Xie, ZF; Xu, XP; Zhang, Y; Zhang, ZW, 2014) |
| "The PFO in Cryptogenic Stroke Study was a 42-center study that evaluated transesophageal echocardiographic findings in patients randomly assigned to warfarin or aspirin in the Warfarin-Aspirin Recurrent Stroke Study." | 5.10 | Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. ( Di Tullio, MR; Homma, S; Mohr, JP; Sacco, RL; Sciacca, RR, 2002) |
| "The combination of clopidogrel for four weeks and aspirin for six months is superior to aspirin alone for six months for preventing migraine with aura after transcatheter closure of an atrial shunt." | 3.73 | Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. ( Morrison, WL; Nightingale, S; Walsh, KP; Wilmshurst, PT, 2005) |
| "The present study was undertaken to evaluate the safety and release of nickel after implantation of a nickel device (Amplatzer occluder) in patients with an atrial septal defect (ASD) receiving antiplatelet therapy." | 3.73 | Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder. ( Brandt, R; Burian, M; Geisslinger, G; Hamm, C; Mitrovic, V; Neumann, T; Weber, M, 2006) |
| "The Patent foramen ovale In Cryptogenic Stroke Study (PICSS) evaluated transesophageal echocardiography findings in patients enrolled in the Warfarin-Aspirin Recurrent Stroke Study, a randomized double-blind trial to evaluate the efficacy of warfarin compared with aspirin." | 3.72 | Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy. ( Di Tullio, MR; Homma, S; Mohr, JP; Sacco, RL; Sciacca, RR, 2003) |
| "Patients with both patent foramen ovale and atrial septal aneurysm who have had a stroke constitute a subgroup at substantial risk for recurrent stroke, and preventive strategies other than aspirin should be considered." | 3.71 | Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. ( Arquizan, C; Cabanes, L; Coste, J; Derumeaux, G; Lamy, C; Mas, JL; Zuber, M, 2001) |
| "The occurrence of new-onset migraine attacks is a complication of transcatheter atrial septal defect (ASD) closure." | 2.80 | Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial. ( Cheema, AN; Côté, M; Horlick, E; Houde, C; Ibrahim, R; Labinaz, M; Marrero, A; Marsal, JR; Nadeem, N; Osten, M; Rivest, D; Rodés-Cabau, J, 2015) |
| " There is no study that assessed the effect of age on adverse event rates in cryptogenic stroke patients with PFO." | 2.71 | Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale. ( DiTullio, MR; Homma, S; Mohr, JP; Sacco, RL; Sciacca, RR, 2004) |
| "We describe a case of thrombus formation on the left atrial disc of a CardioSeal Septal Occlusion device 14 days after transcatheter closure of a patent foramen ovale in a patient with a history of multiple cryptogenic strokes." | 2.42 | Left atrial thrombus formation on a CardioSeal Septal Occlusion device in a patient with elevated factor VIII: resolution with medical therapy. ( Hadley, T; Recto, MR; Sobczyk, W; Yeh, T, 2003) |
| "We report a case of ischaemic stroke in a 34-year-old male recreational bodybuilder following a 3-month period of anabolic androgenic steroid (AAS) use and 1-month period of 'post-cycle therapy' (tamoxifen and clomiphene citrate), the latter treatments aimed at restoring normal endogenous testosterone production after initial AAS use." | 1.62 | Anabolic steroid use and ischaemic stroke in a young fitness enthusiast. ( Choulerton, J; Guha, N; Squires, R, 2021) |
| "There was no clinical occurrence of paradoxical embolism." | 1.37 | Persistent iatrogenic atrial septal defect after pulmonary vein isolation by cryoballoon: an under-recognized complication. ( Chan, NY; Choy, CC; Chu, PS; Lau, CL; Lau, ST; Lo, YK; Mok, NS; Tsui, PT; Yuen, HC, 2011) |
| "Two patients complained of amaurosis fugax at 1 and 3 months after the procedure, and two patients complained of blurred vision at 3 and 4 months after the procedure." | 1.33 | Do complaints of amaurosis fugax and blurred vision after transcatheter device closure of atrial septal defect indicate microemboli to retinal vessels? ( Averbuch, L; Dotan, G; Ehrlich, R; Hirsh, R; Mutzmacher, L, 2005) |
| "Aspirin was usually chosen after initial brain ischemia." | 1.29 | Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. ( Furlan, AJ; Hanna, JP; Sila, CA; Stewart, WJ; Sun, JP; Tan, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (7.89) | 18.2507 |
| 2000's | 25 (65.79) | 29.6817 |
| 2010's | 7 (18.42) | 24.3611 |
| 2020's | 3 (7.89) | 2.80 |
| Authors | Studies |
|---|---|
| Wintzer-Wehekind, J | 1 |
| Horlick, E | 2 |
| Ibrahim, R | 2 |
| Cheema, AN | 2 |
| Labinaz, M | 2 |
| Nadeem, N | 2 |
| Osten, M | 2 |
| Côté, M | 2 |
| Marsal, JR | 2 |
| Rivest, D | 2 |
| Marrero, A | 2 |
| Houde, C | 2 |
| Rodés-Cabau, J | 2 |
| Li, J | 1 |
| Chen, Y | 1 |
| Liu, J | 1 |
| Mai, X | 1 |
| Jing, S | 1 |
| Choulerton, J | 1 |
| Guha, N | 1 |
| Squires, R | 1 |
| Pan, G | 1 |
| Xie, ZF | 1 |
| Zhang, Y | 1 |
| Long, SC | 1 |
| Xu, XP | 1 |
| Zhang, ZW | 1 |
| Seo, JB | 1 |
| Park, KW | 1 |
| Lee, HY | 1 |
| Kang, HJ | 1 |
| Koo, BK | 1 |
| Kim, SH | 1 |
| Kim, HS | 1 |
| Huynh, K | 1 |
| Kimura, M | 1 |
| Kanazawa, H | 1 |
| Kawamura, A | 1 |
| Yamamoto, T | 1 |
| Egashira, T | 1 |
| Kohno, T | 1 |
| Maekawa, Y | 1 |
| Sano, M | 1 |
| Fukuda, K | 1 |
| Castellini, P | 1 |
| Lambru, G | 1 |
| Manzoni, GC | 1 |
| Torelli, P | 1 |
| Gill, PJ | 1 |
| Forbes, K | 1 |
| Coe, JY | 1 |
| Rezaian, GR | 1 |
| Amirghofran, AA | 1 |
| Afifi, S | 1 |
| Moaref, AR | 1 |
| Rezaian, S | 1 |
| Chan, NY | 1 |
| Choy, CC | 1 |
| Lau, CL | 1 |
| Lo, YK | 1 |
| Chu, PS | 1 |
| Yuen, HC | 1 |
| Mok, NS | 1 |
| Tsui, PT | 1 |
| Lau, ST | 1 |
| Lopez-Yunez, AM | 1 |
| Fries, R | 1 |
| Böhm, M | 1 |
| Homma, S | 3 |
| Sacco, RL | 3 |
| Di Tullio, MR | 2 |
| Sciacca, RR | 3 |
| Mohr, JP | 3 |
| Recto, MR | 1 |
| Sobczyk, W | 1 |
| Hadley, T | 1 |
| Yeh, T | 1 |
| Windecker, S | 1 |
| Nedeltchev, K | 1 |
| Wahl, A | 1 |
| Meier, B | 1 |
| Landzberg, MJ | 1 |
| Khairy, P | 1 |
| Elkind, MS | 1 |
| DiTullio, MR | 1 |
| El-Chami, MF | 1 |
| Hanna, IR | 1 |
| Helmy, T | 1 |
| Block, PC | 1 |
| Meier, JM | 1 |
| Delabays, A | 1 |
| Girod, G | 1 |
| Eeckhout, E | 1 |
| Wilmshurst, PT | 1 |
| Nightingale, S | 1 |
| Walsh, KP | 1 |
| Morrison, WL | 1 |
| Ehrlich, R | 1 |
| Mutzmacher, L | 1 |
| Averbuch, L | 1 |
| Dotan, G | 1 |
| Hirsh, R | 1 |
| Burian, M | 1 |
| Neumann, T | 1 |
| Weber, M | 1 |
| Brandt, R | 1 |
| Geisslinger, G | 1 |
| Mitrovic, V | 1 |
| Hamm, C | 1 |
| Schneider, CA | 1 |
| Malani, AK | 1 |
| Ammar, H | 1 |
| Haberl, R | 1 |
| Shichita, T | 1 |
| Yasaka, M | 1 |
| Horne, M | 1 |
| Hanna, JP | 1 |
| Sun, JP | 1 |
| Furlan, AJ | 1 |
| Stewart, WJ | 1 |
| Sila, CA | 1 |
| Tan, M | 1 |
| Manning, WJ | 1 |
| Franke, A | 1 |
| Mas, JL | 1 |
| Arquizan, C | 1 |
| Lamy, C | 1 |
| Zuber, M | 1 |
| Cabanes, L | 1 |
| Derumeaux, G | 1 |
| Coste, J | 1 |
| Du, ZD | 1 |
| Cao, QL | 1 |
| Joseph, A | 1 |
| Koenig, P | 1 |
| Heischmidt, M | 1 |
| Waight, DJ | 1 |
| Rhodes, J | 1 |
| Brorson, J | 1 |
| Hijazi, ZM | 1 |
| Butera, G | 1 |
| Chessa, M | 1 |
| Carminati, M | 1 |
| Halperin, JL | 1 |
| Fuster, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clopidogrel On Top of Aspirin For the Prevention of New Onset Migraine Headache Occurrence Following Transcatheter Closure of Atrial Septal Defects: A Prospective Randomized Trial (the CANOA Study)[NCT00799045] | Phase 4 | 220 participants (Actual) | Interventional | 2008-10-31 | Completed | ||
| Patent Foramen Ovale in Cryptogenic Stroke Study[NCT00697151] | Phase 4 | 630 participants (Actual) | Interventional | 1993-06-30 | Completed | ||
| Medical Treatment With or Without Transcatheter Patent Foramen Ovale CloSure for Older Patients With CrypTogenic StrOke and Patent Foramen Ovale. The STOP Trial[NCT05907694] | 714 participants (Anticipated) | Interventional | 2023-12-01 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for aspirin and Atrial Septal Defect
| Article | Year |
|---|---|
The management of stroke patients by neurologists: common questions and new observations.
Topics: Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Carotid Stenosis; Case Management; Cl | 2002 |
[Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure].
Topics: Abciximab; Acute Disease; Adrenergic beta-Antagonists; Angina, Unstable; Antibodies, Monoclonal; Ant | 2003 |
Left atrial thrombus formation on a CardioSeal Septal Occlusion device in a patient with elevated factor VIII: resolution with medical therapy.
Topics: Aspirin; Blood Coagulation Disorders; Cardiac Surgical Procedures; Echocardiography, Transesophageal | 2003 |
[Cryptogenic stroke and patent foramen ovale].
Topics: Administration, Oral; Adult; Anticoagulants; Aspirin; Echocardiography, Transesophageal; Follow-Up S | 2003 |
Indications for the closure of patent foramen ovale.
Topics: Anticoagulants; Aspirin; Balloon Occlusion; Decision Making; Decompression Sickness; Heart Septal De | 2004 |
The role of warfarin and aspirin in secondary prevention of stroke.
Topics: Anticoagulants; Aspirin; Clopidogrel; Heart Septal Defects, Atrial; Humans; Ischemic Attack, Transie | 2004 |
[Patent foramen ovale and stroke].
Topics: Adult; Age of Onset; Aspirin; Heart Septal Defects, Atrial; Humans; Middle Aged; Platelet Aggregatio | 2004 |
[Options in the management of persistent foramen ovale after an ischemic stroke].
Topics: Aspirin; Brain Ischemia; Heart Septal Defects, Atrial; Humans; Ischemic Attack, Transient; Platelet | 2006 |
[Paradoxical brain embolism].
Topics: Arteriovenous Fistula; Aspirin; Blood Circulation; Embolism, Paradoxical; Heart Aneurysm; Heart Sept | 2006 |
Role of transesophageal echocardiography in the management of thromboembolic stroke.
Topics: Anticoagulants; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Aspirin; Cerebrovascular Disorde | 1997 |
5 trials available for aspirin and Atrial Septal Defect
| Article | Year |
|---|---|
Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Dual Anti-Platelet Therapy; Duration of Therap | 2021 |
Platelet activation through the efficacy of aspirin in congenital heart disease patients undergoing transcatheter closure of atrial septal defects or ventricular septal defects.
Topics: Adolescent; Adult; Aspirin; Cardiac Catheterization; Female; Heart Septal Defects, Atrial; Heart Sep | 2014 |
Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.
Topics: Aspirin; Cardiac Catheterization; Cardiac Surgical Procedures; Clopidogrel; Double-Blind Method; Dru | 2015 |
Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Double-Blind M | 2004 |
Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Double-Blind M | 2004 |
Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Double-Blind M | 2004 |
Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Double-Blind M | 2004 |
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; De | 2002 |
23 other studies available for aspirin and Atrial Septal Defect
| Article | Year |
|---|---|
Is it coincidental or correlative between reversible splenial lesion syndrome and atrial septal defect?: A case report.
Topics: Administration, Oral; Antihypertensive Agents; Aspirin; Brain Diseases; Corpus Callosum; Diffusion M | 2020 |
Anabolic steroid use and ischaemic stroke in a young fitness enthusiast.
Topics: Administration, Intravenous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agent | 2021 |
Comparison of Angiographic Outcomes of Side Branch Ostium at Bifurcation Coronary Lesion between Two-stent and One-stent Techniques.
Topics: Aspirin; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; F | 2015 |
Antiplatelet therapy: Clopidogrel plus aspirin reduces migrane attacks after ASD closure.
Topics: Aspirin; Cardiac Catheterization; Cardiac Surgical Procedures; Female; Headache Disorders, Secondary | 2016 |
Simultaneous transcatheter closure of an atrial septal defect and patent ductus arteriosus in an adult case, followed by thrombocytopenia and subclinical hemolysis.
Topics: Aged; Aspirin; Cardiac Catheterization; Ductus Arteriosus, Patent; Female; Heart Septal Defects, Atr | 2016 |
Atrial septal defect closure and migraine with aura: is there a correlation?
Topics: Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain; Cardiac Surgical Procedu | 2009 |
The effect of short-term prophylactic acetylsalicylic acid on the incidence of postpericardiotomy syndrome after surgical closure of atrial septal defects.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Child; Child, Pr | 2009 |
Nitinol wire mesh fracture and traumatic left atrial thrombus in a patient with atrial septal defect amplatzer occluder.
Topics: Adult; Aspirin; Endocardium; Equipment Failure; Female; Heart Atria; Heart Septal Defects, Atrial; H | 2011 |
Persistent iatrogenic atrial septal defect after pulmonary vein isolation by cryoballoon: an under-recognized complication.
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Catheterization; Cryos | 2011 |
Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy.
Topics: Anticoagulants; Aspirin; Double-Blind Method; Female; Heart Aneurysm; Heart Atria; Heart Septal Defe | 2003 |
Atrial septal abnormalities and cryptogenic stroke: a paradoxical science.
Topics: Anticoagulants; Aspirin; Heart Atria; Heart Septal Defects, Atrial; Heart Septum; Humans; Stroke; Un | 2005 |
Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects.
Topics: Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Heart Septa | 2005 |
Do complaints of amaurosis fugax and blurred vision after transcatheter device closure of atrial septal defect indicate microemboli to retinal vessels?
Topics: Adult; Aged; Amaurosis Fugax; Anticoagulants; Aspirin; Atrial Fibrillation; Catheters, Indwelling; E | 2005 |
Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder.
Topics: Adult; Aged; Alloys; Aspirin; Clopidogrel; Female; Heart Septal Defects, Atrial; Humans; Male; Middl | 2006 |
[Percutaneous closure of patent foramen ovale-- Against].
Topics: Aspirin; Evidence-Based Medicine; Heart Septal Defects, Atrial; Humans; Platelet Aggregation Inhibit | 2006 |
Cryptogenic stroke and patent foramen ovale.
Topics: Aspirin; Heart Septal Defects, Atrial; Humans; Platelet Aggregation Inhibitors; Stroke | 2006 |
Neurology quiz. Patent foramen ovale.
Topics: Adult; Angiography; Aspirin; Echocardiography, Transesophageal; Heart Septal Defects, Atrial; Humans | 1994 |
Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention.
Topics: Adult; Aged; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Echocardiography, Transesophag | 1994 |
[Prevention of embolism in atrial septal defects?].
Topics: Adult; Age Factors; Anticoagulants; Aspirin; Coumarins; Embolism; Female; Fibrinolytic Agents; Heart | 2000 |
Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.
Topics: Adolescent; Adult; Aspirin; Brain Ischemia; Echocardiography, Transesophageal; Female; Follow-Up Stu | 2001 |
Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Catheters, Indwelling; Embolism, Paradoxical; Fema | 2002 |
Warfarin or aspirin for recurrent ischemic stroke.
Topics: Anticoagulants; Aspirin; Heart Septal Defects, Atrial; Humans; Middle Aged; Platelet Aggregation Inh | 2002 |
Patent foramen ovale and recurrent stroke: another paradoxical twist.
Topics: Anticoagulants; Aspirin; Embolism, Paradoxical; Heart Septal Defects, Atrial; Humans; Intracranial E | 2002 |